Skip to main content
    P

    Pasithea Therapeutics Corp (KTTA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.50
    -0.02 (-4.21%)

    Market Cap: $17.44M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    Pasithea Therapeutics Corp (KTTA) Earnings: Report Dates and Results

    Updated Nov 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Pasithea Therapeutics (KTTA) is expected to report earnings on Mar 29, 2027. In the quarter ended Sep 30, 2026, Pasithea Therapeutics reported EPS of -$0.20, above the -$0.21 estimate. It beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    46%(6/13)
    Avg Surprise
    -30.48%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 29, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.26
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    KTTA has an expected report date of Mar 29, 2027.

    Earnings History

    Of the 13 quarters below that had an estimate, KTTA beat 6, missed 5 and matched 2. The widest gap in the table came in the quarter ended Mar 31, 2022, when EPS landed 422.50% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.20-$0.21-$0.21 - -$0.21+4.76%BeatN/A11 up, 0 downNov 13, 2026N/A
    Jun 30, 2026-$0.16-$0.16-$0.16 - -$0.160.00%In lineN/A11 up, 0 downAug 14, 2026N/A
    Mar 31, 2026-$0.12-$0.45-$0.45 - -$0.45+73.33%BeatN/A10 up, 0 downMay 15, 2026N/A
    Dec 31, 2025-$0.89-$0.18N/A-394.44%MissN/AN/AN/AFeb 25, 2026N/A
    Sep 30, 2025-$0.41N/AN/AN/AN/AN/AN/AN/ANov 13, 2025N/A
    Jun 30, 2025-$0.66N/AN/AN/AN/AN/AN/AN/AAug 14, 2025N/A
    Mar 31, 2025-$1.61N/AN/AN/AN/AN/AN/AN/AMay 15, 2025N/A
    Dec 31, 2024-$2.53N/AN/AN/AN/AN/AN/AN/AMar 24, 2025$649028
    Sep 30, 2024-$2.87N/AN/AN/AN/AN/AN/AN/ANov 13, 2024N/A
    Jun 30, 2024-$3.71N/AN/AN/AN/AN/AN/AN/AAug 13, 2024N/A
    Mar 31, 2024-$3.70N/AN/AN/AN/AN/AN/AN/AMay 14, 2024N/A
    Dec 31, 2023-$4.85-$3.80N/A-27.54%MissN/AN/A0 up, 1 downMar 28, 2024$976306
    Sep 30, 2023-$0.14-$0.18N/A+20.22%BeatN/AN/A0 up, 1 downDec 29, 2023N/A
    Jun 30, 2023-$2.84-$3.40N/A+16.47%BeatN/AN/AN/AAug 11, 2023N/A
    Mar 31, 2023-$2.47-$3.40N/A+27.35%BeatN/AN/AN/AMay 12, 2023N/A
    Dec 31, 2022-$0.18-$0.18N/A0.00%In line-250.0%N/AN/AMar 30, 2023$240712
    Sep 30, 2022-$3.20-$2.80N/A-14.29%MissN/AN/A0 up, 0 downNov 14, 2022N/A
    Jun 30, 2022-$2.63-$2.20N/A-19.55%MissN/AN/A0 up, 0 downAug 15, 2022N/A
    Mar 31, 2022-$2.09-$0.40N/A-422.50%MissN/AN/A0 up, 0 downMay 16, 2022N/A
    Dec 31, 2021$0.12-$0.05-$0.05 - -$0.05+340.00%BeatN/A10 up, 0 downMar 30, 2022$15062
    Sep 30, 2021-$0.12N/AN/AN/AN/AN/AN/AN/ANov 18, 2021N/A
    Jun 30, 2021-$0.05N/AN/AN/AN/AN/AN/AN/ASep 16, 2021N/A
    Mar 31, 2021-$0.09N/AN/AN/AN/AN/AN/AN/AJun 30, 2021N/A
    Dec 31, 2020-$0.07N/AN/AN/AN/AN/AN/AN/AMar 31, 2021N/A
    Jun 30, 2020$0.00N/AN/AN/AN/AN/AN/AN/ASep 30, 2020N/A
    Last 25 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$3.57, after -$12.81 the year before. It was -$0.07 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$3.57N/A
    Dec 31, 2024-$12.81N/A
    Dec 31, 2023-$10.30N/A
    Dec 31, 2022-$8.10N/A
    Dec 31, 2021-$0.14N/A
    Dec 31, 2020-$0.07N/A

    Frequently Asked Questions About KTTA

    When is Pasithea Therapeutics's next earnings date?

    Pasithea Therapeutics's next earnings report is expected for Mar 29, 2027.

    Did KTTA beat earnings estimates last quarter?

    Yes. Pasithea Therapeutics reported EPS of -$0.20 for the quarter ended Sep 30, 2026, above the -$0.21 estimate, a 4.76% surprise.

    What EPS do analysts expect from KTTA next quarter?

    The consensus EPS estimate for Pasithea Therapeutics for the quarter ending Dec 31, 2026 is -$0.26 from 3 analysts.

    How often does KTTA beat earnings estimates?

    Pasithea Therapeutics beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate, with an average surprise of -34.98%.